Compounds > gadofosveset trisodium
Page last updated: 2024-09-04

gadofosveset trisodium and Nephrogenic Systemic Fibrosis

gadofosveset trisodium has been researched along with Nephrogenic Systemic Fibrosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Åkesson, M; Leander, P; Lehti, L; Sterner, G; Wassélius, J1
Akeson, P; Akesson, M; Alhadad, A; Leander, P; Lehti, L; Sterner, G; Wassélius, J1
Kay, J; Todd, DJ1
Chrysochou, C; Husain, S; Kalra, PA; Lay, J; Moser, S; Power, A; Salama, AD; Shurrab, AE1
Perazella, MA; Reilly, RF1

Reviews

1 review(s) available for gadofosveset trisodium and Nephrogenic Systemic Fibrosis

ArticleYear
Gadolinium-Induced Fibrosis.
    Annual review of medicine, 2016, Volume: 67

    Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Terminology as Topic

2016

Other Studies

4 other study(ies) available for gadofosveset trisodium and Nephrogenic Systemic Fibrosis

ArticleYear
Long-term safety of Gadofosveset in clinical practice.
    Magnetic resonance imaging, 2022, Volume: 86

    Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Retrospective Studies

2022
Safety aspects of gadofosveset in clinical practice--analysis of acute and long-term complications.
    Magnetic resonance imaging, 2014, Volume: 32, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Retrospective Studies; Risk Assessment; Young Adult

2014
Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging.
    Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:3

    Topics: Adult; Aged; Chronic Disease; Contrast Media; England; Female; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Kidney Diseases; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors

2010
Imaging patients with kidney disease: how do we approach contrast-related toxicity?
    The American journal of the medical sciences, 2011, Volume: 341, Issue:3

    Topics: Acute Kidney Injury; Contrast Media; Diagnostic Imaging; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Informed Consent; Iodine Radioisotopes; Magnetic Resonance Imaging; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Patient Selection; Radiopharmaceuticals; Renal Artery Obstruction; Risk Assessment; Risk Factors; Tomography, X-Ray Computed

2011